info@seagull-health.com
SeagullHealth
语言:
search
new
Alpelisib Medication Guide
500
Article source: Seagull Pharmacy
Jul 07, 2025

Alpelisib is a treatment for specific breast cancer patients. Its use must strictly follow the doctor's instructions and medication guidelines to clarify the treatment effect and reduce the risk of adverse reactions. This article will comprehensively introduce the relevant information of Alpelisib from three aspects: medication guidelines, purchase guidelines and patient dietary guidelines, to help patients better manage and use this drug.

Alpelisib Medication Guide

The use of Alpelisib requires precise control of dosage and usage, while paying close attention to possible adverse reactions.

Usage and Dosage

The recommended dose of Alpelisib is 300mg per day, that is, two 150mg film tablets, which must be taken with food. Patients should take the medicine at the same time every day and swallow the whole tablet without chewing, crushing or splitting. If a dose is missed, it can be taken within 9 hours, and the dose of the day will be skipped if it exceeds. When used in combination with Fulvestrant, the dosing regimen of Fulvestrant must be followed.

Adverse reaction management

Alpelisib may cause adverse reactions such as increased blood sugar, diarrhea, and rash. Patients should monitor blood sugar regularly, especially in the early stages of treatment, and pay attention to any abnormal symptoms. For severe allergic reactions, adverse skin reactions, hyperglycemia, pneumonia, diarrhea or colitis, the drug should be discontinued immediately and medical treatment should be sought. At the same time, patients should understand and recognize the signs and symptoms of these adverse reactions so that timely measures can be taken.

During the medication process, patients should maintain close communication with their doctors and adjust the dosage or treatment plan in a timely manner according to the condition and adverse reactions.

Buying Guide for Alpelisib

Alpelisib is an imported drug, and its purchase should consider price, source and legality.

Price and Specifications

The price of Alpelisib varies by specification and region. For example, the specification of the original drug exported to Hong Kong is 150mg*56 tablets; while the Indian version has multiple specifications and is relatively low in price. When purchasing, patients should choose the appropriate specifications and prices according to their own economic conditions and medication needs.

Purchase Channels

It is recommended to choose a reputable pharmacy or online platform and verify the authenticity and source of the drug. At the same time, patients should be careful to avoid buying counterfeit and inferior drugs to avoid damage to the body.

When purchasing Alpelisib, patients should be vigilant and make sure that the source of the drug is legal, the price is reasonable and the quality is reliable.

Dietary Guide for Alpelisib Patients

A reasonable diet is important for improving the therapeutic effect of Alpelisib and reducing the risk of adverse reactions.

Dietary Recommendations

While taking Alpelisib, patients should maintain a balanced diet and eat more foods rich in protein, vitamins and minerals. At the same time, sugar intake should be controlled to avoid high-sugar foods that cause blood sugar to rise. In addition, eating more fiber-rich foods can help relieve adverse reactions such as diarrhea.

Dietary Taboos

Patients should avoid eating spicy, greasy and irritating foods during medication to avoid increasing the burden on the gastrointestinal tract. At the same time, foods and drugs that interact with Alpelisib, such as strong CYP3A inducers, should be avoided. If in doubt, consult a doctor or pharmacist in time.

Through a reasonable diet, patients can better cooperate with the treatment of Alpelisib, improve the quality of life and prolong survival.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
 Alpelisib(PIQRAY)
Alpelisib(PIQRAY)
PIQRAY is indicated in combination with fulvestrant for the treatment of...
WeChat Scan
Free Inquiry
Recommended Articles
How much does a course of Alpelisib cost
Alpelisib is an innovative drug for specific breast cancer patients. The cost of treatment, drug overdose treatment and purchase channels are of particular concern to patients and their families....
How to buy Alpelisib
Alpelisib is a treatment for a specific type of breast cancer, and its purchase process should be treated with caution. This article aims to provide a guide on how to purchase Alpelisib, while em...
PIK3CA inhibitor Alpelisib instructions - indications - marketing - dosage and use - side effects
Alpelisib is a targeted drug for breast lesions with specific gene mutations, which exerts anti-lesion effects by inhibiting the PI3Kα signaling pathway. Its indications and global marketing progress ...
Indications of Alpelisib
Alpelisib is an innovative targeted therapy drug that brings new hope for treatment of patients with specific types of breast cancer with its unique mechanism of action. This article aims to expl...
Alpelisib studies have proven to significantly delay disease progression
Alpelisib is a targeted drug for PIK3CA-mutated breast lesions, which has shown significant efficacy in delaying disease progression in multiple clinical studies. Its combination with fulvestrant prov...
Are the side effects of Alpelisib serious?
Alpelisib is an inhibitor that targets the PI3K pathway, specifically the PI3Kα isoform. Mutations in the PIK3CA gene are widely present in a variety of cancers, leading to overactive PI3K signal...
What are the precautions for Alpelisib (PIQRAY)?
Alpelisib (PIQRAY) is a targeted therapy for patients with breast-related diseases with specific gene mutations. Its unique mechanism of action brings new hope for treatment for patients with bre...
How to buy Dornase Alfa(Pulmozyme)
Pulmozyme is an innovative drug for the treatment of cystic fibrosis (CF). It improves the patient's respiratory function by reducing the accumulation of viscous mucus.How to buy Dornase Alfa(Pulm...
Related Articles
How to Use Alpelisib (Piqray)
Alpelisib (Piqray) is a kinase inhibitor, first approved in the United States in 2019. Used in combination with fulvestrant, this medication provides an important targeted treatment option for patient...
What Kind of Drug Is Alpelisib (Piqray)?
Alpelisib (Piqray) is a kinase inhibitor, first approved in the United States in 2019. As a targeted therapy for specific types of advanced breast cancer, it exerts its effects by inhibiting the PI3Kα...
How to Purchase Alpelisib (Piqray)
Alpelisib (Piqray) is a phosphatidylinositol-3-kinase (PI3K) inhibitor. It is indicated for adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative...
Precautions for the Administration of Alpelisib (Piqray)
Alpelisib (Piqray) is a phosphatidylinositol-3-kinase (PI3K) inhibitor administered orally, and strict adherence to dosage adjustments and adverse reaction monitoring is required.Precautions for the A...
What are the precautions for Alpelisib (PIQRAY)?
Alpelisib (PIQRAY) is a targeted therapy for patients with breast-related diseases with specific gene mutations. Its unique mechanism of action brings new hope for treatment for patients with bre...
Are the side effects of Alpelisib serious?
Alpelisib is an inhibitor that targets the PI3K pathway, specifically the PI3Kα isoform. Mutations in the PIK3CA gene are widely present in a variety of cancers, leading to overactive PI3K signal...
Alpelisib studies have proven to significantly delay disease progression
Alpelisib is a targeted drug for PIK3CA-mutated breast lesions, which has shown significant efficacy in delaying disease progression in multiple clinical studies. Its combination with fulvestrant prov...
Alpelisib Medication Guide
Alpelisib is a treatment for specific breast cancer patients. Its use must strictly follow the doctor's instructions and medication guidelines to clarify the treatment effect and reduce the r...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved